In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

New research shows a single psilocybin session with therapy can reduce depression in cancer patients for up to two years.

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

Grail announced that results from the registrational PATHFINDER 2 study of its Galleri multi-cancer early detection test ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...

New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

A single dose of psilocybin shows lasting relief from depression and anxiety in cancer patients, in latest clinical trials.